This page lists 10 bladder cancer doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
Quick answer
This page lists 10 bladder cancer doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Bladder cancer doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
About the Condition
What is Bladder cancer?
Bladder cancer occurs when abnormal cells develop in the lining of the bladder, most commonly the urothelial (transitional) cells that form the inner surface of the bladder wall. It is one of the more common urological cancers and, if detected early, has relatively favourable outcomes — but delayed diagnosis or high-grade disease can allow spread into deeper muscle layers or beyond the bladder, significantly affecting prognosis. Key risk factors include a history of smoking, occupational exposure to certain chemicals (such as aromatic amines used in dye or rubber industries), chronic bladder irritation, and previous pelvic radiation. A thorough assessment — including personal and family medical history, relevant imaging, and tissue examination — is essential before any treatment pathway can be recommended.
Individual assessmentEvery case is different
Complete evaluationUnderstand the condition first
Specialist reviewChoose the right approach
Medical assessment helps clarify severity and identify appropriate options.
Treatment options for Bladder cancer
Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
Robotic-assisted radical cystectomy is a minimally invasive surgical procedure to remove the entire bladder (and nearby lymph nodes, prostate/seminal vesicles in men or uterus/ovaries in women) in patients with muscle-invasive or high-risk bladder cancer.
Why it may be consideredA surgeon uses a robotic surgical system to perform the operation through small incisions, followed by creation of a new way for urine to leave the body (urinary diversion). It offers reduced blood loss, less pain, and faster recovery compared to open surgery, with similar cancer control outcomes.
Radical cystectomy is the surgical removal of the entire urinary bladder, along with nearby lymph nodes and, depending on the patient, the prostate and seminal vesicles in men or the uterus and part of the vagina in women.
Why it may be consideredIt is the standard treatment for muscle-invasive bladder cancer and for high-risk or recurrent non-muscle-invasive disease, and is followed by creation of a new way for urine to leave the body (urinary diversion). The goal is complete cancer removal while preserving quality of life through modern reconstructive techniques.
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Many international patients consider India for bladder cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
How this directory is built
Doctors are matched using the specialty, location, condition (Bladder cancer) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Bladder cancer in India
What is Bladder cancer?
Bladder cancer is a malignancy that most commonly originates in the urothelial cells lining the inside of the bladder, and is classified by how deeply it has grown into the bladder wall (non-muscle-invasive versus muscle-invasive) and by the aggressiveness of the cancer cells (grade). These two factors together guide every subsequent clinical decision.
What are the symptoms and health risks of Bladder cancer?
The most frequently reported symptom is blood in the urine (haematuria), which may be visible to the naked eye or detectable only on laboratory testing; other symptoms can include a persistent urge to urinate, pain or burning during urination, and, in more advanced disease, pelvic pain or back pain. Some individuals have no noticeable symptoms in the early stages, and haematuria has many potential causes beyond cancer. Symptoms alone are never sufficient to establish or exclude a diagnosis — formal clinical and pathological evaluation is always required.
How is Bladder cancer diagnosed?
Diagnosis typically begins with a urine analysis and urine cytology (examining shed cells under a microscope), followed by cystoscopy — a direct visual inspection of the bladder interior using a thin, flexible or rigid scope. If suspicious tissue is identified, a transurethral resection of the bladder tumour (TURBT) is performed both to obtain a biopsy and, for superficial tumours, as an initial treatment; the resulting pathology report establishes the tumour grade and the depth of invasion, which are then used alongside CT urography or MRI to assign a clinical stage (typically using the TNM system). The combination of stage and grade determines the individual's risk category and informs which treatment options are most appropriate.
How is Bladder cancer treated?
Treatment is highly individualised and depends on the tumour's stage, grade, and the patient's overall health. Non-muscle-invasive bladder cancer is often managed with endoscopic resection followed by intravesical therapy (medicines instilled directly into the bladder), while muscle-invasive or high-risk disease generally requires more intensive intervention. For eligible patients with muscle-invasive bladder cancer, radical cystectomy — the surgical removal of the bladder, performed as an open or robotic-assisted procedure — combined with neoadjuvant (pre-operative) chemotherapy represents a standard-of-care approach, though bladder-sparing strategies and systemic therapies are also considered in carefully selected cases.
Can Bladder cancer be treated without surgery?
Non-surgical options play a meaningful role in bladder cancer management and include intravesical immunotherapy (most commonly BCG instilled into the bladder) or intravesical chemotherapy for non-muscle-invasive disease, as well as systemic chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapies for advanced or metastatic disease. Bladder-preserving trimodality therapy — combining maximal TURBT, radiation, and concurrent chemotherapy — is an established alternative to cystectomy for selected patients with muscle-invasive disease who are not surgical candidates or prefer to avoid bladder removal. Active surveillance with regular cystoscopy is appropriate for carefully monitored low-risk cases, but a qualified clinician must assess whether any non-surgical pathway is suitable for a given individual.
When is Robotic-assisted radical cystectomy considered for Bladder cancer?
Robotic-assisted radical cystectomy may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.
Which doctor treats Bladder cancer?
Bladder cancer is primarily evaluated and managed by a urologist — specifically one with subspecialty expertise in urological oncology — and, for advanced or complex cases, by a multidisciplinary team that typically includes a medical oncologist (for systemic and intravesical therapies) and a radiation oncologist (when bladder-preserving chemoradiation is considered). Uro-oncology nurse specialists and pathologists with genitourinary expertise are also important members of a comprehensive care team.
How do I choose a doctor for Bladder cancer?
When selecting a provider for bladder cancer treatment, it is worth asking about the surgeon's or centre's volume of TURBT procedures and radical cystectomies (including robotic-assisted cases), whether a dedicated multidisciplinary uro-oncology tumour board reviews cases, and what follow-up surveillance protocols are in place — since bladder cancer has a notable recurrence rate that requires long-term monitoring. Accreditation of the facility and access to the full range of treatment options, from intravesical therapy through to robotic surgery and systemic oncology, are also practical factors to compare.
What documents do international patients need to share for a medical evaluation?
Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.
